Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

(2021) Ajaz A. Bhat et al.   Molecular Cancer

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

(2021) Ronan J. Kelly et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-8 and cancer prognosis on immunotherapy

(2020) Ziad Bakouny et al.   NATURE MEDICINE

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors

(2020) Kurt A. Schalper et al.   NATURE MEDICINE

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade

(2020) Kobe C. Yuen et al.   NATURE MEDICINE

Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial

(2020) Ursula Nestle et al.   RADIOTHERAPY AND ONCOLOGY

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

(2020) Andressa S Laino et al.   Journal for ImmunoTherapy of Cancer

Plasma IL-6 changes correlate to PD-1 inhibitor responses in NSCLC

(2020) Alissa Keegan et al.   Journal for ImmunoTherapy of Cancer

The Integration of Radiotherapy With Immunotherapy for the Treatment of Non-Small Cell Lung Cancer

(2018) Eric C. Ko et al.   CLINICAL CANCER RESEARCH

Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging

(2018) Ahmed Salem et al.   Clinical Lung Cancer

Randomized phase II study of pembrolizumab after stereotactic body radiotherapy (SBRT) versus pembrolizumab alone in patients with advanced non-small cell lung cancer: The PEMBRO-RT study.

(2018) Willemijn Theelen et al.   JOURNAL OF CLINICAL ONCOLOGY

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

(2018) Scott J. Antonia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between serum cytokines and progression of breast cancer in Chinese population

(2017) Haiyan Wang et al.   MEDICINE

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

(2017) Claire Vanpouille-Box et al.   Nature Communications

Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

(2017) Helen Ha et al.   Theranostics

Barriers to Radiation-Induced In Situ Tumor Vaccination

(2017) Erik Wennerberg et al.   Frontiers in Immunology

Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer

(2017) Elena Muraro et al.   Frontiers in Immunology

Prognostic value of circulating inflammatory factors in non-small cell lung cancer: A systematic review and meta-analysis

(2017) Chen Liao et al.   Cancer Biomarkers

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?

(2017) Eleni Gkika et al.   PLoS One

Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers

(2016) Roni Allaoui et al.   Nature Communications

Immunological markers that predict radiation toxicity

(2015) Carl N. Sprung et al.   CANCER LETTERS

Contribution of the immune system to bystander and non-targeted effects of ionizing radiation

(2015) Franz Rödel et al.   CANCER LETTERS

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer

(2015) Rebecca S. Heist et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting IL-11 signaling in colon cancer

(2015) Matthias Ernst et al.   Oncotarget

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

(2014) S. J. Dovedi et al.   CANCER RESEARCH

A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

(2014) Bríd M. Ryan et al.   Journal of Thoracic Oncology

IL-6 and related cytokines as the critical lynchpins between inflammation and cancer

(2014) Koji Taniguchi et al.   SEMINARS IN IMMUNOLOGY

Cytokines, Fatigue, and Cutaneous Erythema in Early Stage Breast Cancer Patients Receiving Adjuvant Radiation Therapy

(2014) Vitaliana De Sanctis et al.   Biomed Research International

Is tumor (R)ejection by the immune system the “5th R” of radiobiology?

(2014) Encouse Golden et al.   OncoImmunology

Combinations of Immunotherapy and Radiation in Cancer Therapy

(2014) Ralph E. Vatner et al.   Frontiers in Oncology

Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer

(2013) C. Bodelon et al.   ANNALS OF ONCOLOGY

STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation

(2012) Hazel Tye et al.   CANCER CELL

Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer

(2012) Nasser Ghaly Yousif et al.   CYTOKINE

Combining Physical and Biologic Parameters to Predict Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Definitive Radiation Therapy

(2012) Matthew H. Stenmark et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Therapy to Convert the Tumor Into an In Situ Vaccine

(2012) Silvia C. Formenti et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Microenvironment and Radiation Therapy

(2012) Michio Yoshimura et al.   Biomed Research International

The convergence of radiation and immunogenic cell death signaling pathways

(2012) Encouse B. Golden et al.   Frontiers in Oncology

The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment

(2011) Ning Li et al.   CANCER CELL

Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients

(2011) M. Łukaszewicz-Zając et al.   DISEASES OF THE ESOPHAGUS

Cancer immunotherapy comes of age

(2011) Ira Mellman et al.   NATURE

Predictive Factors of Late Radiation Fibrosis: A Prospective Study in Non–Small Cell Lung Cancer

(2010) Renaud Mazeron et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Serum Concentrations of Cytokines and Lung Cancer Survival in African Americans and Caucasians

(2009) L. Enewold et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Elevation of Plasma TGF-β1 During Radiation Therapy Predicts Radiation-Induced Lung Toxicity in Patients With Non-Small-Cell Lung Cancer: A Combined Analysis From Beijing and Michigan

(2009) Lujun Zhao et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistant mice

(2009) Xiaoping Ao et al.   Journal of Hematology & Oncology

Cytokine Plasma Levels: Reliable Predictors for Radiation Pneumonitis?

(2008) Claudia E. Rübe et al.   PLoS One

Effect of Radiation on Gene Expression of Rat Liver Chemokines:In VivoandIn VitroStudies

(2008) Federico Moriconi et al.   RADIATION RESEARCH